Innospec Inc. (IOSP): Price and Financial Metrics
Innospec Inc. (IOSP)
Today's Latest Price: $96.61 USD
Updated Jan 22 4:00pm
Add IOSP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
IOSP Stock Summary
- IOSP's current price/earnings ratio is 63.11, which is higher than 83.21% of US stocks with positive earnings.
- The ratio of debt to operating expenses for Innospec Inc is higher than it is for about just 11.35% of US stocks.
- With a year-over-year growth in debt of -81.77%, Innospec Inc's debt growth rate surpasses only 2.85% of about US stocks.
- Stocks that are quantitatively similar to IOSP, based on their financial statements, market capitalization, and price volatility, are MTRN, BRC, ASTE, PERI, and FLWS.
- IOSP's SEC filings can be seen here. And to visit Innospec Inc's official web site, go to www.innospecinc.com.
IOSP Stock Price Chart Interactive Chart >
IOSP Price/Volume Stats
| Current price | $96.61 | 52-week high | $107.85 |
| Prev. close | $95.51 | 52-week low | $56.71 |
| Day low | $93.19 | Volume | 127,700 |
| Day high | $96.77 | Avg. volume | 114,536 |
| 50-day MA | $88.71 | Dividend yield | 1.09% |
| 200-day MA | $76.76 | Market Cap | 2.37B |
Innospec Inc. (IOSP) Company Bio
Innospec manufactures and supplies a wide range of specialty chemicals worldwide. The Fuel Specialties business specializes in manufacturing and supplying the fuel additives that help improve fuel efficiency, boost engine performance and reduce harmful emissions. This business also contains Oilfield Specialties which provides specialty chemicals for oil & gas drilling and production operations. The Performance Chemicals business provides solutions for processes or products focused in the Personal Care and Polymers markets. The company was founded in 1938 and is based in Englewood, Colorado.
IOSP Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $96.61 | $44.19 | -54% |
Below please find a table outlining a discounted cash flow forecast for IOSP, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Innospec Inc ranked in the 34th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for IOSP, they are:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 99. Its equity weight surpasses that of 93.7% of free cash flow generating stocks in the Basic Materials sector.
- The business' balance sheet reveals debt to be 1% of the company's capital (with equity being the remaining amount). Approximately merely 7.36% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- IOSP's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 51.21% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -55% |
| 1% | -54% |
| 2% | -54% |
| 3% | -53% |
| 4% | -53% |
| 5% | -52% |
KWR, SUZ, IFF, FSI, and MTX can be thought of as valuation peers to IOSP, in the sense that they are in the Basic Materials sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...